Ligand validation:3ZWI

ASC: ASCORBIC ACID

ASC is a Ligand Of Interest in 3ZWI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZWI_ASC_A_156	24%	29%	0.169	0.795	1.5	1.36	3	2	2	0	100%	0.75
2YLG_ASC_A_130	97%	44%	0.068	0.985	1.17	1.01	1	2	1	0	100%	1
5JLI_ASC_A_202	60%	27%	0.153	0.939	1.34	1.58	1	3	1	0	100%	1
2YLD_ASC_A_130	40%	30%	0.156	0.866	1.64	1.17	2	1	2	0	100%	0.75
4CIP_ASC_A_130	16%	20%	0.195	0.765	2.08	1.31	1	1	3	0	100%	0.5
5JRA_ASC_A_202	9%	18%	0.163	0.647	2.27	1.26	2	3	1	0	100%	0.7
1E73_ASC_M_995	93%	2%	0.066	0.961	4.52	2.31	8	5	1	0	100%	1
4RP9_ASC_A_501	93%	28%	0.093	0.988	1.62	1.27	1	2	0	0	100%	1
4TVT_ASC_A_303	87%	23%	0.086	0.956	1.22	1.93	2	5	1	0	100%	0.7
8DJT_ASC_A_302	85%	13%	0.097	0.963	2.49	1.54	3	2	0	0	100%	1
4RP8_ASC_C_501	84%	19%	0.112	0.974	1.9	1.59	1	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.